Delivery Order SPE2DB25D3404-SPE2DB25FUNZB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) valued at $2,446.24. This competitively awarded, firm fixed-price delivery order was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The contract represents a non-set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valsartan-HCTz 320-25 mg tablets (90-count) with a ceiling value of $4,853.07. This is a firm fixed price delivery order with an award date of December 1, 2025, and an ultimate completion date of December 2, 2025. The contract utilizes no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Valsartan-HCTZ 320-12.5 mg tablets in a 90-count quantity, with a ceiling value of $2,955.68. This firm fixed-price delivery order, with an ultimate completion date of November 6, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $77,079.86 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Valsartan-HCTZ 320-12.5 mg tablets in quantities of 90 units. This firm fixed-price delivery order, which was not set-aside and competed openly, is scheduled for completion by September 12, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) under a firm fixed-price contract valued at $2,040.27. The award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, carries no set-aside designation and represents a competitive award. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,542.97 to AmerisourceBergen Drug Corp for Valsartan-HCTZ 320-25 mg tablets (90-count supply). This competitively awarded, firm fixed-price delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. As a child delivery order under a...
- The Defense Logistics Agency awarded a delivery order valued at $2,282.30 to AmerisourceBergen Drug Corp for Valsartan-HCTZ 320-25 mg tablets (90-count supply) on November 24, 2025, with an ultimate completion date of November 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) under a firm fixed-price contract valued at $7,909.65. This is a non-set-aside award issued on December 1, 2025, with an ultimate completion date of December 2, 2025. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office and primary operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,087.30 to AmerisourceBergen Drug Corp for Valsartan-HCTZ 160-25 mg tablets (90-count supply) on November 26, 2025, with completion scheduled for November 28, 2025. This is a firm fixed price delivery order with no set-aside designation, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under a competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) on November 4, 2025, with a ceiling value of $1,464.89 and a firm fixed price contract type. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. The award was made on a...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUNZBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Valsartan-HCTZ 320-25 mg tablets (90-count supply) valued at $1,549.78 under a firm fixed price contract. The award was made on June 24, 2025, with an ultimate completion date of June 25, 2025, and is classified as a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this delivery order, which represents a child contract under a larger indefinite delivery vehicle. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The underlying contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and the U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 6/24/25 |